For many years guanethidine (Ismelin) has been a widely us cd drug for the control of severe hypertension, Its hypotensive effect stems from moderate reduction of cardiae output Sll in combination with decreased peripheral vascular resistance." 1:' Both effects are the result of catecholamine depletion in the adrenergic nerve endings in the myocardium and the blood vessel walls. Some of the side effects of guanethidine are disturbing, e.g., its tendency to cause carly morning hypotension G • Hand diarrhea, In addition, the slow onset of action and the sustained effect following withdrawal!;·!J often make fine adjustments of blood pressure control difficult in patients. For these reasons, there has long been a need for a drug with the potency of guanethidine but without some of its undesirable effects.
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Guanadrel, which was introduced recently, is an adrenergic blocking agent with hypotensive action. It is similar to guanethidine in many ways and acts by causing a peripheral catecholamine depletion. 7 However, its effect is conSiderably shorter than that of guanethidine, being in the order of 6 to 8 hours." Thus, it would seem possible to achieve a more balanced control of blood pressure throughout the day. As initial results with guanadrel seemed to suggest complete absence of diarrhea and less morning hypotension than with guanethidine,' the present study was undertaken. Our main interest has been to study the hemodynamie effects of oral treatment with guanadrel and to compare the blood pressure control and side effects of guanadrel and guanethidine.
Materials and methods
Twenty-one patients with moderately severe hypertension took part in the study: 19 males and 2 females whose average age was 41 years (range 17 to 68). Only patients in whom diuretic trcatment alone had failed to control the blood pressure were selected. All were without overt heart failure (less than Grade Il, New York Heart Association classification), severe kidney failure (creatinine clearance over 40 m!. per minute), or Grades III and IV hypertensive retinopathy (Keith-WagenerBarker) . Twenty patients had essential hypertension, as determined after complete laboratory work-up including: serum electrolytes, urinary ketosteroids, catecholamines, and aldosteronc, as well as normal hypertensive urograms. One patient had chronic pyelonephritis with sccondary hypertension. Eight patients were chosen for evaluation of the hemodynamic effect of both drugs. These patients were studied in the early phase whcn initial experience was needed in an open label design. The aim of the treatment was to achieve best practical blood pressure control with increasing doses of both compounds. Best practical control was defined as normal blood pressure or lowest possible reading without causing intractablc side effects after a minimum of 6 or maximum of 12 weeks of treatment. At the end of each period, intra- artcrial blood pressures were measured and cardiac outputs were determined by dye dilution technique. The method has been described in detail previously.':! Thirtecn patients were chosen for a single-blind crossover study to compare the effect of both drugs on home blood pressure rccorded by patients who were unaware of the treatment regimen. Side effects were evaluated by a "blind" observer who used a standardized questionnaire. Patients were receiving chlorothiazide, 50 mg. 2 times daily, and the "active" drug for 2 periods each 6 weeks in length. Between those 2 periods there was a 2 week period of placebo when the only active treatment was chlorothiazide. Two of the authors (L. Hansson and A. Pascual) were in touch with patients and adjusting the "active drug" to achieve the best practical blood pressure control. Randomization was assured by predetermined closed envelopes so that patients started with either guanadrel or guanethidine. Six patients were started with guanadrel, while 7 received guanethidine during the first period of active treatment. The average daily dosage of guanadrel was 70 mg. (25 to 150) and of guanethidine, 57 mg. (25 to 125). Guanethidine was administered once daily while guanadrel was used in 3 divided doses.
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Hansson, Pascual, and ]ulius
Clinical Pharmacology and TherapetlUcs The student t test for paired observations has been used in all statistical comparisons. When comparing the effect on the blood pressure, the average home blood pressure recordings during the last 7 days of guanadrel, guanethidine, and placebo treatment. respectively, have been used.
Results
Randomized study. Blood pressure control. As can be seen in Table I , both guanadrel and guanethidine caused a significant reduction of blood pressure. There was no significant differ-0.05 ns ence in antihypertensive potency of the active drugs. In the afternoon, both recumbent and standing diastolic blood pressures increased Significantly more during treatment with guanethidine (Table 11) . This, however, was not the case with systolic blood pressure.
Side effects. Both drugs caused a number of side effects (Table Ill) . Complaints of failure of ejaculation were made by 10 patients after both drugs. Only 2 patients complained of early morning dizziness during guanadrel treatment as compared to 7 after guanethidine. Diarrhea occurred in 3 patients during the guanadrel period and in 6 while taking guanethidine. The total number of complaints during guanadrel treatment was 70, 93 during guanethidine, and 67 during "placebo" therapy.
Hemodynamic effects. There was no significant difference between the effects of guanethidine and guanadrel on heart rate, intra-arterial blood pressure, cardiac index, and total peripheral vascular resistance either in the recumbent or tilted position (Table IV) . Both drugs caused a marked reduction of cardiac output during tilt, with a substantial drop of systolic blood pressure and a moderate increase of total peripheral resistance.
Discussion
In a randomized single-blind cross-over study, both guanadrel and guanethidine decreased blood pressure to the same extent, probably by similar hemodynamic mechanisms since no significant differences of cardiac output or total peripheral re- = tota penphera resJstance ; 1 = car me In ex ltel'S mm. 0 y sur ace area .
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sistance were detected. However, the usually observed rise in blood pressure throughout the day during guanethidine therapy was not seen after guanadrel. Consequently, morning to afternoon changes of recumbent and standing diastolic blood pressure were larger with guanethidine (p < 0.05). This difference may be attributed to the shorter duration of the guanadrel effect, which necessitates administration 3 times daily, but in turn gives a more stable control of the blood pressure. On the other hand, it has been shown that the early morning hypotension of guanethidine treatment persists even if the drug is administered 3 times daily.G The complaints of dizziness upon rising were also more frequent during the guanethidine period and thus further support the impression that guanadrel offers a more even control of blood pressure.
Another important side effect of guanethidine treatment is diarrhea; again, guanadrel caused fewer complaints. This may be attributed to the fact that guanadrel depletion of intestinal catecholamine stores is less than quanethidine depletion. 10 Other side effects such as failure of ejaculation seem to be equally frequent. The surprisingly high frequency of this complaint during the intervening placebo period is of interest, but may be attributable to the short duration of placebo.
In summary, the following conclusions can be drawn: (1) The hypotensive effective and other hemodynamic effects of guanadrel are comparable to those of guanethidine. (2) Guanadrel provides a more stable control of the blood pressure characterized bv a more even reduction of diastolic blood pressure throughout the day. (3) Diarrhea is less frequent during treatment with guanadrel.
